Evidence map›Paper›PMID 28868241›Full record

ArticleTranslational cancer research2017

Targeting cancer with tumor-specific therapeutic strategies-metabolic reprogramming beyond the Warburg effect.

Paul Grippo, Ajay V Maker

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Paul GrippoDepartment of Medicine, Division of Gastroenterology, University of Illinois at Chicago, Chicago, IL, USA.
Ajay V MakerDepartment of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, IL, USA.

Funding

Non Invasive Treatment Response Monitoring and molecular characterization of NSCLC using Cell-free DNA isolated by an AC Electrokinetic DeviceR01CA161283 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GRIPPO, PAUL J · 2012 to 2016
$1.8M
Enhancing anti-tumor immune responses in colon cancer metastasesK08CA190855 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAKER, AJAY V. · 2014 to 2018
$909k
NCI NIH HHS K08 CA190855NCI NIH HHS R01 CA161283
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28868241
PMCPMC5578475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.